Macquarie Group Ltd. raised its stake in Balchem Co. (NASDAQ:BCPC) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 398,513 shares of the basic materials company’s stock after purchasing an additional 13,444 shares during the period. Macquarie Group Ltd. owned 1.24% of Balchem worth $31,223,000 as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in BCPC. BlackRock Inc. lifted its holdings in Balchem by 1.1% in the fourth quarter. BlackRock Inc. now owns 4,697,980 shares of the basic materials company’s stock valued at $368,087,000 after acquiring an additional 50,467 shares during the period. Vanguard Group Inc. lifted its holdings in Balchem by 2.6% in the third quarter. Vanguard Group Inc. now owns 3,252,944 shares of the basic materials company’s stock valued at $364,622,000 after acquiring an additional 81,119 shares during the period. Vanguard Group Inc increased its position in shares of Balchem by 2.6% in the third quarter. Vanguard Group Inc now owns 3,252,944 shares of the basic materials company’s stock valued at $364,622,000 after buying an additional 81,119 shares in the last quarter. Conestoga Capital Advisors LLC increased its position in shares of Balchem by 6.2% in the fourth quarter. Conestoga Capital Advisors LLC now owns 795,884 shares of the basic materials company’s stock valued at $62,358,000 after buying an additional 46,305 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Balchem by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 746,533 shares of the basic materials company’s stock valued at $58,492,000 after buying an additional 10,660 shares in the last quarter. Institutional investors own 87.80% of the company’s stock.
Balchem stock traded down $0.02 during midday trading on Friday, reaching $97.98. 113,099 shares of the company were exchanged, compared to its average volume of 104,669. The stock has a market cap of $3.16 billion, a PE ratio of 32.55 and a beta of 1.00. Balchem Co. has a 1 year low of $73.16 and a 1 year high of $117.79. The company has a current ratio of 2.76, a quick ratio of 1.94 and a debt-to-equity ratio of 0.24.
A number of research analysts have recently weighed in on BCPC shares. Seaport Global Securities started coverage on Balchem in a research report on Thursday, February 21st. They issued a “neutral” rating for the company. BidaskClub upgraded Balchem from a “sell” rating to a “hold” rating in a research report on Wednesday, February 20th. HC Wainwright set a $101.00 price target on Balchem and gave the company a “buy” rating in a research report on Tuesday, February 5th. Finally, Zacks Investment Research cut Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th. One analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $105.50.
WARNING: This report was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/macquarie-group-ltd-has-31-22-million-holdings-in-balchem-co-bcpc.html.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
See Also: Systematic Risk
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.